Cancer patients have not always had the best opportunities and that is because a huge part of cancer treatment is that people cannot get the true cure for the disease because it doesn’t exist. While cancer treatment is in place to help people out, it does not always have the best side effects and patients often die from these issues more than they do from cancer because of the problems that it presents to the patients. There are many who are unable to experience the opportunities that they have in the cancer treatment field because they didn’t have what they needed to feel better with the issues that they had.As things continued to get better for cancer patients, Mikhail Blagosklonny knew that he wanted to do even more. He wanted to expedite the process and make it easier for cancer patients to get the treatment that they deserved. He did this through a peer review publication. This is what allowed doctors to connect with each other and learn more about cancer and the way that it had an effect on the body.
The cancer treatment opportunities would grow when doctors worked together to figure out what they could do. They did not have this opportunity before Mikhail Blagosklonny came along.The idea behind the cancer treatment options that he had for people to learn more about was that he was going to create this publication that would show people what they could do to help their patients feel better. This publication was called Oncotarget and it was intended for oncologists so that they could help out with different issues. It was also something that made sense for Mikhail Blagosklonny because he would be able to use it to make things easier on his patients while he was working to treat them for the various issues that they had.After realizing that it would be helpful, Mikhail Blagosklonny made the choice to add even more doctors to the mix of doctors who were already a part of Oncotarget.
While the ones who were oncologists were very important, he also saw a lot of value in having other specialists be a part of the publication. He used them to get the information that he needed treatment because he knew that it couldn’t just come from those who had already studied everything that they could about cancer.For this reason, things like anti-aging treatment for immune problems as a result of cancer treatment became a possibility. It was something that Mikhail Blagosklonny knew a lot about and something that made it easier for him to try and make better for different people. He tried his best to experience more and offer more options for his patients so that they could try and get more out of the situations that they were in. All of this helped people to see more and to do more with their own practice so that they had the resources necessary to help all of their patients with treatment.
Dr. Scott Rocklage was asked of a trend that he finds very interesting and exciting right now. He responded by saying he he thinks the ability to now target specific types of mutations or genotypes to help treat cancer is an incredible development in oncology. Dr. Rocklage says that these development have already helped save lives and extend the lifespan of many others suffering from cancer. Dr. Scott Rocklage expects many more developments in this field and he finds it very exciting.
Another question posed to Scott Rocklage of 5AM Ventures was if he was to start his business over again, would would he do differently the next time around. Dr. Rocklage’s answer was that he would concentrate much more on the people at his company. People are what make the company grow and prosper and building a good team should not be underestimated in any business says Rocklage.
Next, Ideamensch asked what is one thing that that Scott Rocklage does constantly in business that he suggests other people try out themselves. Scott Rocklage says that one of the best thing any entrepreneur can do is take measured risk taking. He went on to say that you have the best grip on your own future when you have your own business and not when you work for a Fortune 500 company. Taking measured risks and having your own business will let you try new opportunities and have the greatest control of your own life summarizes Scott Rocklage. That is a very empowering thing to have and learn more about Scott.
Scott Rocklage was asked about a strategy that has helped him to expand his business and how it has done so. The strategy that has helped Scott Rocklage expand his firm’s business is a simple one. He says that simply staying true to what his firm knows how to do best and not moving too far away from the company’s strength has been a proven successful strategy for him. Keeping this in mind is especially important when things get tough says Rocklage. During tough times, it is tempting to move away from what your specialize and to try a new trend instead. This could backfire tremendously though and Scott avoids putting himself in such a situation and his Linkedin.
More visit: http://5amventures.com/team/scott-m-rocklage-phd/
Cancer has been attributed to causing many deaths across the world. This is because it is categorized as one of the chronic diseases that is very expensive to cure. As a result, many organizations have been founded to try and find the cure to the disease that has been contributed to many deaths globally. Many people have also taken key interest in specializing and studying cancer cases in a bid to combat the disease. Clay Siegall is the co-founder and president of the Seattle Genetics which is a center for scientific research and drug development. The center also takes keen interest in helping patients understand the type of diseases affecting them and how to manage or treat it. As such, Clay Siegall vast knowledge in the field of scientific research has brought a lot of change regarding the development of advance drugs to cure chronic diseases like cancer. He has spearheaded the development of antibody-drug conjugates that have been using used in over 60 countries across the world. These are drugs that have helped mitigate and treat many cases of cancer.
According to http://www.bizjournals.com/seattle/blog/health-care-inc/2016/03/seattle-genetics-ambitious-plan-for-12-more-drugs.html, Clay Siegall received a lot of recognition when the then Vice President of the united states of America JoeBiden visited Seattle Genetics. As a result, many media houses have focused on the company and Clay Siegall in particular. He also seeks to grow the company into a multinational entity and produced more effective drugs to curb the spread of cancer. Due to its rapid expansion, the company has opened employment opportunities to over 100 employees adding to the existing number of personnel. Clay Siegall responsibility at the company is to make sure the research being done to develop new drugs meets international standards. He is mandated with releasing tested and proven cancer treatment drugs that have also elevated the name of his company. Research is carried out on a daily basis in a bid to keep on with the emerging market trends and technological advancement. His innovative capabilities made him start capital raising activity in order to enable the research center perform to its fullest. As a result he raised over $1.2billion from the public